Postpartum depression isn’t just a mother’s battle—new study says dads are facing it too. Key signs to watch out for; expert ...
Sage Therapeutics Inc. (NASDAQ:SAGE) confirmed that Biogen Inc. (NASDAQ:BIIB) submitted an unsolicited, nonbinding proposal ...
Masaba Gupta shares her postpartum journey returning to work before 40 days Discover the importance of recovery bonding and ...
Researchers conducted an ancillary prespecified analysis to examine the prevalence of postpartum depression and its risk factors 2 months post-cesarean delivery.
There was, however, one shining exception: The two days my new family spent at the Ahma & Co postnatal retreat at the Waldorf ...
Biogen proposes acquiring Sage Therapeutics for $7.22 per share, as analysts highlight the strategic value of Zurzuvae's ...
PPD can happen to dads too, a new study shows. Experts share their insight. Fatherhood is always evolving, and more men are ...
With biting honesty and vivid prose, Sarah Hoover’s memoir dismantles the glossy veneer of motherhood. Arno Reyes Baetz for ...
Maternal exposure to elevated temperatures during the postpartum period is associated with an increased risk of postpartum ...
Sage Therapeutics, Inc. (Nasdaq: SAGE) saw its stock price soar by an impressive 33.87%, reaching $7.43 during Monday’s premarket trading session. The surge came on the heels of the company’s ...
In comparison with the vast epidemiological literature on postpartum depression (PPD), relatively few studies have examined the biological aspects of the disorder. However, research into the ...